In uncontrolled type 2 diabetes, adjunctive semaglutide reduced HbA1c and body weight vs sitagliptin.

In uncontrolled type 2 diabetes, adjunctive semaglutide reduced HbA1c and body weight vs sitagliptin. Ann Intern Med. 2019 Aug 20;171(4):JC16 Authors: Lipscombe LL PMID: 31426059 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31426059?dopt=Abstract

Source: Annals of Internal Medicine - August 19, 2019 Category: Internal Medicine Authors: Lipscombe LL Tags: Ann Intern Med Source Type: research

More News: Diabetes | Diabetes Type 2 | Endocrinology | Internal Medicine | Januvia